Hematology/Oncology

Top Story

SLACK Incorporated Appoints Matt Holland Chief Commercial Officer

October 18, 2018
FDA News

Imbruvica-Gazyva combination receives priority review for chronic lymphocytic leukemia

October 17, 2018
The FDA granted priority review to ibrutinib in combination with obinutuzumab for the treatment of previously untreated adults with chronic lymphocytic leukemia or small…
Feature

Tinder-style app helps medical students identify melanoma

October 17, 2018
A smartphone app may help medical students more accurately differentiate melanomas from benign skin lesions, according to study results published in JAMA
In the Journals Plus

Phone-based weight-loss intervention may be effective for breast cancer survivors

October 17, 2018
Female breast cancer survivors who adhered to a 12-month weight-loss intervention program that used telephone-based counseling were able to lose an average of 7.6% of…
In the Journals Plus

Increase in mortality with daily aspirin attributable to cancer

October 17, 2018
Healthy older adults who used aspirin daily had higher mortality rates, primarily driven by cancer-related death, than those who took placebo, according a randomized…
More Headlines »
CME

Multimodality Treatment Strategies for NSCLC: A Symposium at the US Oncology Annual Meeting

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. Approximately 85% of diagnosed lung cancers are non-small…
More »
Video
Meeting News

VIDEO: CMS Quality Payment Program continues to challenge physicians

August 16, 2018
More »
Resource Centers

CME CPE CNE

Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Current Issues
View the Current Issue
HemOnc Today